Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Alessandra Vultaggio and Andrea Matucci.
Connection Strength

2.413
  1. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.897
  2. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
    View in: PubMed
    Score: 0.888
  3. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.228
  4. Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
    View in: PubMed
    Score: 0.061
  5. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2904-2906.e2.
    View in: PubMed
    Score: 0.059
  6. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
    View in: PubMed
    Score: 0.057
  7. Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19. Allergy Rhinol (Providence). 2020 Jan-Dec; 11:2152656720968804.
    View in: PubMed
    Score: 0.057
  8. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020; 4:53-68.
    View in: PubMed
    Score: 0.056
  9. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
    View in: PubMed
    Score: 0.056
  10. COVID-19: general overview, pharmacological options and ventilatory support strategies. Multidiscip Respir Med. 2020 Jan 28; 15(1):708.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.